Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
Pannus P, Depickère S, Kemlin D, Georges D, Houben S, Olislagers V, Waegemans A, De Craeye S, Francotte A, Chaumont F, Van Oostveldt C, Heyndrickx L, Michiels J, Willems E, Dhondt E, Krauchuk M, Schmickler MN, Verbrugghe M, Van Loon N, Dierick K, Matagne A, Desombere I, Ariën KK, Marchant A, Goossens ME. Pannus P, et al. Among authors: heyndrickx l. Vaccine. 2023 Apr 24;41(17):2829-2836. doi: 10.1016/j.vaccine.2023.03.047. Epub 2023 Mar 27. Vaccine. 2023. PMID: 36997386 Free PMC article.
Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity.
Cham F, Zhang PF, Heyndrickx L, Bouma P, Zhong P, Katinger H, Robinson J, van der Groen G, Quinnan GV Jr. Cham F, et al. Among authors: heyndrickx l. Virology. 2006 Mar 30;347(1):36-51. doi: 10.1016/j.virol.2005.11.019. Epub 2005 Dec 27. Virology. 2006. PMID: 16378633 Free article.
Boosting of HIV-1 neutralizing antibody responses by a distally related retroviral envelope protein.
Uchtenhagen H, Schiffner T, Bowles E, Heyndrickx L, LaBranche C, Applequist SE, Jansson M, De Silva T, Back JW, Achour A, Scarlatti G, Fomsgaard A, Montefiori D, Stewart-Jones G, Spetz AL. Uchtenhagen H, et al. Among authors: heyndrickx l. J Immunol. 2014 Jun 15;192(12):5802-12. doi: 10.4049/jimmunol.1301898. Epub 2014 May 14. J Immunol. 2014. PMID: 24829409 Free PMC article.
Human immunodeficiency virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides.
Selhorst P, Vazquez AC, Terrazas-Aranda K, Michiels J, Vereecken K, Heyndrickx L, Weber J, Quiñones-Mateu ME, Ariën KK, Vanham G. Selhorst P, et al. Among authors: heyndrickx l. Antimicrob Agents Chemother. 2011 Apr;55(4):1403-13. doi: 10.1128/AAC.01426-10. Epub 2011 Jan 31. Antimicrob Agents Chemother. 2011. PMID: 21282453 Free PMC article.
Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission.
Ariën KK, Venkatraj M, Michiels J, Joossens J, Vereecken K, Van der Veken P, Abdellati S, Cuylaerts V, Crucitti T, Heyndrickx L, Heeres J, Augustyns K, Lewi PJ, Vanham G. Ariën KK, et al. Among authors: heyndrickx l. J Antimicrob Chemother. 2013 Sep;68(9):2038-47. doi: 10.1093/jac/dkt166. Epub 2013 May 3. J Antimicrob Chemother. 2013. PMID: 23645585
142 results